Literature DB >> 27582499

Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis.

Santosh Kumar Goru1, Almesh Kadakol1, Anuradha Pandey1, Vajir Malek1, Nisha Sharma1, Anil Bhanudas Gaikwad1.   

Abstract

Hyperglycaemia-induced expression of extracellular matrix (ECM) components plays a major role in the development of diabetic nephropathy (DN). The epigenetic mechanisms that modulate ECM gene expression in DN remain unclear. Therefore, we examined the role of histone H2A and H2B monoubiquitination on epigenetic chromatin marks, such as histone H3 lysine dimethylation (H3K4Me2, H3K9Me2 and H3K79Me2) in type 1 diabetic rat kidney. Hyperglycaemia increased collagen deposition and Col1a1 gene expression. In whole kidney of diabetic animals, both H2AK119 mono-ubiquitination (H2AK119Ub) and H2BK120 mono-ubiquitination (H2BK120Ub) were found to be increased, whereas, in glomeruli of diabetic animals, expression of both H2AK119Ub and H2BK120Ub was reduced. Changes in ubiquitin proteasome system components like increased Rnf2 (H2A-specific E3 ligase) and decreased H2A- and H2B-specific deubiquitinases (ubiquitin-specific proteases 7, 16, 21 and 22) were also observed. Globally increased levels of chromatin marks associated with active genes (H3K4Me2 and H3K79Me2) and decreased levels of repressive marks (H3K9Me2) were also observed. Hyperglycaemia also increased the protein expression of SET7/9 and decreased the expression of SUV39H1. We also showed the decreased occupancy of H2AK119Ub and H2BK120Ub on the promoters of Set7/9 and Suv39h1 in diabetic kidney. In addition, methylation marks regulated by H2AK119Ub (H3K27Me2 and H3K36Me2) and H2BK120Ub (H3K4Me2 and H3K79Me2) were also found to be altered on the promoters of Set7/9 and Suv39h1 Taken together, these results show the functional role of H2AK119Ub and H2BK120Ub in regulating histone H3K4Me2 and H3K9Me2 through modulating the expression of SET7/9 and SUV39H1 in the development of diabetic renal fibrosis.
© 2016 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  H2AK119 mono-ubiquitination; H2BK120 mono-ubiquitination; histone H3 lysine dimeth; histone H3 lysine dimethylation; renal fibrosis; type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27582499     DOI: 10.1042/BCJ20160595

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.

Authors:  Santosh Kumar Goru; Almesh Kadakol; Vajir Malek; Anuradha Pandey; Nisha Sharma; Anil Bhanudas Gaikwad
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

Review 2.  Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease.

Authors:  Jing Liu; Qingqing Wei; Chunyuan Guo; Guie Dong; Yu Liu; Chengyuan Tang; Zheng Dong
Journal:  Int J Mol Sci       Date:  2017-04-30       Impact factor: 5.923

Review 3.  Chemical probes targeting epigenetic proteins: Applications beyond oncology.

Authors:  Suzanne Ackloo; Peter J Brown; Susanne Müller
Journal:  Epigenetics       Date:  2017-01-12       Impact factor: 4.528

Review 4.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

5.  Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.

Authors:  Hong Ding; Wen Chao Lu; Jun Chi Hu; Yu-Chih Liu; Chen Hua Zhang; Fu Lin Lian; Nai Xia Zhang; Fan Wang Meng; Cheng Luo; Kai Xian Chen
Journal:  Molecules       Date:  2018-03-02       Impact factor: 4.411

Review 6.  The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases.

Authors:  Xun Zhou; Hui Chen; Jinqing Li; Yingfeng Shi; Shougang Zhuang; Na Liu
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

7.  Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma.

Authors:  Monika Bauden; Theresa Kristl; Agata Sasor; Bodil Andersson; György Marko-Varga; Roland Andersson; Daniel Ansari
Journal:  BMC Cancer       Date:  2017-12-02       Impact factor: 4.430

8.  Changing expression profiles of long non-coding RNAs, mRNAs and circular RNAs in ethylene glycol-induced kidney calculi rats.

Authors:  Yanan Cao; Xiaowei Gao; Yue Yang; Zhi Ye; E Wang; Zhitao Dong
Journal:  BMC Genomics       Date:  2018-09-10       Impact factor: 3.969

Review 9.  Histone Methyltransferases as Therapeutic Targets for Kidney Diseases.

Authors:  Chao Yu; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

Review 10.  The Dynamics and Plasticity of Epigenetics in Diabetic Kidney Disease: Therapeutic Applications Vis-à-Vis.

Authors:  Feng-Chih Kuo; Chia-Ter Chao; Shih-Hua Lin
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.